J. E. da C. Gomes, P. F. P. dos Santos, and V. M. Alvarenga, “CARDIOVASCULAR BENEFITS OF CANAGLIFLOZIN USE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: AN INTEGRATIVE REVIEW”, REASE, vol. 11, no. 10, pp. 5153–5165, Oct. 2025, doi: 10.51891/rease.v11i10.21802.